Frontlight ResearchEarly access
Trial site
Ehime Prefectural Central Hospital
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis4 trials
- Heart failure2 trials
- Acute myeloid leukaemia1 trial
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Multiple myeloma1 trial
- Phase
- Phase 38 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Abivax S.A.2 trials
- Boehringer Ingelheim2 trials
- Bayer1 trial
- Bristol-Myers Squibb1 trial
- Daiichi Sankyo1 trial
- and 5 more
Running trials
Recruiting
Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Coronary artery disease1 recruiting
- Multiple myeloma1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026